Contact this trialFirst, we need to learn more about you.
Orexin Receptor Antagonist
Suvorexant for Alcoholism
Recruiting0 awardsPhase 1 & 2
Bethesda, Maryland
"This trial will investigate how the drug Suvorexant affects dopamine receptors in people with alcohol use disorder (AUD) and in healthy individuals. Participants with AUD will undergo alcohol detoxification in the clinic
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service